 | Up a level |
Journal Article
Ayachi, O., Barlin, M., Nia, S. Bozorg, Kashkar, H., Zigrino, P. and Mauch, C. (2016). XIAP down regulation inhibits invasion of melanoma cells by regulating cell migration and survival. Exp. Dermatol., 25 (3). S. E38 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1600-0625
Ayachi, O., Zigrino, P., Kashkar, H. and Mauch, C. (2014). XIAP down-regulation reduced migration and invasion of human metastatic melanoma cells. Exp. Dermatol., 23 (3). S. E47 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1600-0625
Batinica, M., Akguel, B., Schilling, S., Mauch, C. and Zigrino, P. (2015). Correlation of Merkel cell polyomavirus positivity with PDGFRa mutations and survivin expression in Merkel cell carcinoma. J. Invest. Dermatol., 135. S. S26 - 1. NEW YORK: NATURE PUBLISHING GROUP. ISSN 1523-1747
Batinica, M., Akguel, B., Silling, S., Mauch, C. and Zigrino, P. (2015). Correlation of Merkel cell polyomavirus positivity with PDGFR alpha mutations and survivin expression in Merkel cell carcinoma. J. Dermatol. Sci., 79 (1). S. 43 - 50. CLARE: ELSEVIER IRELAND LTD. ISSN 1873-569X
Bunde, H., Stoelzel, F., Grosskopf-Kroiher, D., Seidel, N., Mauch, C. and Breitbart, E. W. (2018). Primary skin cancer prevention - target group: children and young people. Oncol. Res. Treat., 41. S. 41 - 42. BASEL: KARGER. ISSN 2296-5262
De Craene, B., Denecker, G., Vermassen, P., Taminau, J., Mauch, C., Derore, A., Jonkers, J., Fuchs, E. and Berx, G. (2014). Epidermal Snail expression drives skin cancer initiation and progression through enhanced cytoprotection, epidermal stem/progenitor cell expansion and enhanced metastatic potential. Cell Death Differ., 21 (2). S. 310 - 321. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5403
Franklin, C., Wetter, A., Baba, H. A., Cosgarea, I., Mauch, C., Livingstone, E., Zimmer, L., Schadendorf, D. and Ugurel, S. (2020). The diagnostic Significance of CT-controlled Puncture in Skin Cancer Patients. J. Dtsch. Dermatol. Ges., 18. S. 27 - 28. HOBOKEN: WILEY. ISSN 1610-0387
Ghatak, S., Niland, S., Schulz, J., Wang, F., Mauch, C., Krieg, T., Zigrino, P. and Eckes, B. (2016). Combined loss of integrins alpha 1 beta 1 and alpha 2 beta 1 results in reduced angiogenesis in mice. J. Invest. Dermatol., 136 (9). S. S255 - 1. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1523-1747
Giebeler, N., Schoenefu, A., Landsberg, J., Tueting, T., Mauch, C. and Zigrino, P. (2016). ADAM-9 modulates melanoma development and metastasis in vivo. Exp. Dermatol., 25 (3). S. E38 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1600-0625
Giebeler, N., Schoenefuss, A., Landsberg, J., Tueting, T., Mauch, C. and Zigrino, P. (2017). ADAM9 modulates melanoma development and metastasis. J. Invest. Dermatol., 137 (10). S. S282 - 1. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1523-1747
Giebeler, N., Schoenefuss, A., Landsberg, J., Tuting, T., Mauch, C. and Zigrino, P. (2017). Deletion of ADAM-9 in HGF/CDK4 mice impairs melanoma development and metastasis. Oncogene, 36 (35). S. 5058 - 5068. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5594
Grau, S., Herling, M., Mauch, C., Galldiks, N., Golla, H., Schlamann, M., Scheel, A. H., Celik, E., Ruge, M. and Goldbrunner, R. (2021). Brain metastases-Interdisciplinary approach towards a personalized treatment. Chirurg, 92 (3). S. 200 - 210. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0385
Grob, J. -J., Amonkar, M. M., Martin-Algarra, S., Demidov, L. V., Goodman, V., Grotzinger, K., Haney, P., Kaempgen, E., Karaszewska, B., Mauch, C., Miller, W. H., Jr., Millward, M., Mirakhur, B., Rutkowski, P., Chiarion-Sileni, V., Swann, S. and Hauschild, A. (2014). Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazine. Ann. Oncol., 25 (7). S. 1428 - 1437. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041
Hassel, J. C., Sucker, A., Edler, L., Kurzen, H., Moll, I., Stresemann, C., Spieth, K., Mauch, C., Rass, K., Dummer, R. and Schadendorf, D. (2010). MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome. Br. J. Cancer, 103 (6). S. 820 - 827. LONDON: NATURE PUBLISHING GROUP. ISSN 1532-1827
Heindl, L. M., Koch, K. R., Schlaak, M., Mauch, C. and Cursiefen, C. (2015). Adjuvant therapy and interdisciplinary follow-up care of conjunctival melanoma. Ophthalmologe, 112 (11). S. 907 - 912. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0423
Heuser, S., Hufbauer, M., Steiger, J., Marshall, J., Sterner-Kock, A., Mauch, C., Zigrino, P. and Akguel, B. (2016). The fibronectin/alpha 3 beta 1 integrin axis serves as molecular basis for keratinocyte invasion induced by beta HPV. Oncogene, 35 (34). S. 4529 - 4540. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5594
Hoerster, R., Schlaak, M., Koch, K. R., Ortmann, M., Mauch, C. and Heindl, L. M. (2017). Merkel cell carcinoma of the eyelid. An often unrecognized tumor entity. Clinical aspects and treatment strategies. Ophthalmologe, 114 (2). S. 134 - 140. NEW YORK: SPRINGER. ISSN 1433-0423
Kleffner, F., Kremer, K., Schlaak, M., Mauch, C. and Kurschat, P. (2012). Cutaneous Angiosarcoma: difficult to treat by Tumor. J. Dtsch. Dermatol. Ges., 10 (11). S. 860 - 861. HOBOKEN: WILEY-BLACKWELL. ISSN 1610-0379
Kleffner, F., Schuerholz, J., Burckhardt, S., Mauch, C. and Schlaak, M. (2014). Merkel cell carcinoma. Hautarzt, 65 (9). S. 823 - 831. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1173
Kleffner, F., Schuerholz, J., Burckhardt, S., Mauch, C. and Schlaak, M. (2015). Merkel-Cell-Carcinoma (vol 65, pg 823, 2014). Hautarzt, 66 (1). S. 52 - 53. NEW YORK: SPRINGER. ISSN 1432-1173
Kleffner-Mieth, F., Brenner, N., Tantcheva-Poor, I, Schlaak, M. and Mauch, C. (2015). Sweet-Syndrome in Ipilimumab- Therapy in Combination with Radiotherapy in a Patient with metastatic malignant Melanoma. J. Dtsch. Dermatol. Ges., 13 (12). S. 1325 - 1326. HOBOKEN: WILEY-BLACKWELL. ISSN 1610-0387
Knuever, J., Gerecht, L., Mauch, C. and Schlaak, M. (2017). Eosinophilia during immunotherapy of metastatic melanoma: A warning signal for possible side effects? J. Dtsch. Dermatol. Ges., 15. S. 70 - 72. HOBOKEN: WILEY. ISSN 1610-0387
Knuever, J., Gerecht, L., Naetlitz, M., Mauch, C. and Schlaak, M. (2017). Eosinophilia during immunotherapy of metastatic melanoma -a warning signal for possible side effects? J. Dtsch. Dermatol. Ges., 15. S. 167 - 168. HOBOKEN: WILEY. ISSN 1610-0387
Knuever, J., Gerecht, L., Naetlitz, M., Mauch, C. and Schlaak, M. (2017). Eosinophilia during immunotherapy of metastatic melanoma-A warning signal for possible side effects? Exp. Dermatol., 26 (3). S. E32 - 1. HOBOKEN: WILEY. ISSN 1600-0625
Knuever, J., Schlaak, M. and Mauch, C. (2016). Eosinophils during immunotherapies of metastatic melanoma - cause or consequence of treatment responses and side effects? J. Dtsch. Dermatol. Ges., 14. S. 32 - 33. HOBOKEN: WILEY-BLACKWELL. ISSN 1610-0387
Kunz, M., Dannemann, M., Dose, G., Kelso, J., Hoffmann, S., Landsberg, J., Tueting, T., Zigrino, P., Mauch, C., Kottek, T., Utikal, J., Schulze, H., Ziemer, M., Simon, J., Bosserhoff, A. and Schartl, M. (2017). RNA-Seq analysis of benign melanocytic nevi and primary melanomas. Exp. Dermatol., 26 (3). S. E86 - 1. HOBOKEN: WILEY. ISSN 1600-0625
Leufke, C., Leykauf, J., Krunic, D., Jauch, A., Holtgreve-Grez, H., Boehm-Steuer, B., Broecker, E-B, Mauch, C., Utikal, J., Hartschuh, W., Purdie, K. J. and Boukamp, P. (2014). The telomere profile distinguishes two classes of genetically distinct cutaneous squamous cell carcinomas. Oncogene, 33 (27). S. 3506 - 3519. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5594
Maniu, C., Kobe, C., Krieg, T., Schlaak, M., Mauch, C. and Eming, S. A. (2015). Polymyalgia rheumatica under the Therapy with Ipilimumab. J. Dtsch. Dermatol. Ges., 13 (12). S. 1322 - 1323. HOBOKEN: WILEY-BLACKWELL. ISSN 1610-0387
Mauch, C., Doetsch, J., Tantcheva-Poor, I. and Striegel, A. (2014). Parvovirus B19-associated generalized purpuric rash in a 12-year-old girl. J. Dtsch. Dermatol. Ges., 12. S. 32 - 33. HOBOKEN: WILEY-BLACKWELL. ISSN 1610-0387
Mescher, M., Jeong, P., Ruebsam, M., Kranen, M., Landsberg, J., Schlaak, M., Mauch, C., Tueting, T., Niessen, C. M. and Iden, S. (2016). Non-cell autonomous suppression of melanoma by the epidermal polarity protein Par3 through control of direct keratinocyte-melanocyte interactions. J. Invest. Dermatol., 136 (9). S. S244 - 1. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1523-1747
Mescher, M., Ruebsam, M., Jeong, P., Kranen, M., Landsberg, J., Schlaak, M., Mauch, C., Niessen, C. M., Tueting, T. and Iden, S. (2015). The epidermal polarity protein Par3 acts as non-cell autonomous suppressor of malignant melanoma. J. Invest. Dermatol., 135. S. S20 - 1. NEW YORK: NATURE PUBLISHING GROUP. ISSN 1523-1747
Moro, N., Schoenefuss, A., Landsberg, J., Tueting, T., Mauch, C. and Zigrino, P. (2014). ADAM-9 deletion in an animal model with spontaneous melanoma development reduces lung metastases formation. Exp. Dermatol., 23 (3). S. E43 - 2. HOBOKEN: WILEY-BLACKWELL. ISSN 1600-0625
Moro, N., Schoenefuss, A., Landsberg, J., Tueting, T., Mauch, C. and Zigrino, P. (2014). DELETION OF ADAM-9 IN AN ANIMAL MODEL WITH SPONTANEOUS MELANOMA DEVELOPMENT REDUCES LUNG METASTASIS FORMATION. Wound Repair Regen., 22 (5). S. A92 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1524-475X
Moro, N., Schoenefuss, A., Landsberg, J., Tueting, T., Mauch, C. and Zigrino, P. (2014). Dual role for ADAM-9 in melanoma development and metastasis in vivo. J. Invest. Dermatol., 134. S. S90 - 1. NEW YORK: NATURE PUBLISHING GROUP. ISSN 1523-1747
Moro, N., Schoenefuss, A., Landsberg, J., Tueting, T., Mauch, C. and Zigrino, P. (2015). Melanoma-derived ADAM-9 modulates melanoma development and metastasis in vivo. Exp. Dermatol., 24 (3). S. E39 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1600-0625
Moro, N., Schoenefuss, A., Landsberg, J., Tueting, T., Mauch, C. and Zigrino, P. (2015). Melanoma-derived ADAM-9 modulates melanoma development and metastasis in vivo. Exp. Dermatol., 24 (3). S. E39 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1600-0625
Moro, N., Schoenefuss, A., Mauch, C. and Zigrino, P. (2015). Down-regulation of ADAM-9 in human melanoma cells impairs their invasiveness. J. Invest. Dermatol., 135. S. S24 - 1. NEW YORK: NATURE PUBLISHING GROUP. ISSN 1523-1747
Neumann, S., Kuemper, M., Mauch, C. and Zigrino, P. (2018). Endothelial cell-derived MMP-14 is dispensable for skin formation and repair. Int. J. Exp. Pathol., 99 (6). S. A38 - 1. HOBOKEN: WILEY. ISSN 1365-2613
Niels, T., Kaba-Velten, G., Luther, I., Muench, C., Cama, F., Christ, H., Euteneuer, A., Klug-Micu, G. M., Mauch, C. and Grosskopf-Kroiher, D. (2018). Skin cancer prevention training in elementary schools: Increasing the awareness towards UV-radiation. Oncol. Res. Treat., 41. S. 41 - 43. BASEL: KARGER. ISSN 2296-5262
Persa, O. D., Loquai, C., Wobser, M., Baltaci, M., Dengler, S., Kreuter, A., Volz, A., Laimer, M., Emberger, M., Doerler, M., Mauch, C. and Helbig, D. (2019). Extended surgical safety margins and ulceration are associated with an improved prognosis in pleomorphic dermal sarcomas. J. Eur. Acad. Dermatol. Venereol., 33 (8). S. 1577 - 1581. HOBOKEN: WILEY. ISSN 1468-3083
Pflug, N., Vitus, M., Knuever, J., Hamacher, S., Mauch, C., Schlaak, M. and Theurich, S. (2021). Treatment-specific evaluation of the modified Glasgow-Prognostic-Score in patients with advanced cutaneous melanoma. J. Eur. Acad. Dermatol. Venereol., 35 (12). S. E879 - 5. HOBOKEN: WILEY. ISSN 1468-3083
Scheer, M., Drebber, U., Krakowezki, A., Mauch, C., Zoeller, J. E. and Kreppel, M. (2014). Influence of Podoplanin Expression in Cutaneous Squamous Cell Carcinoma of the Head- Neck- Regions of the Lymphogenic Metastasis and the Prognosis. J. Dtsch. Dermatol. Ges., 12. S. 9 - 10. HOBOKEN: WILEY-BLACKWELL. ISSN 1610-0387
Schlaak, M., Bajah, A., von Bartenwerffer, W., Kreuzberg, N., Buettner, N., Mauch, C. and Kurschat, P. (2011). Clinical Characterization of Melanoma patients with and without activating BRAF Mutation. J. Dtsch. Dermatol. Ges., 9 (11). S. 976 - 977. MALDEN: WILEY-BLACKWELL. ISSN 1610-0379
Schlaak, M., Dummer, R., Kirkwood, J. M., Joshua, A., Milhem, M., Gastaud, L., Mauch, C., Yushak, M. L., Lockwood, S., Hayes, C. and Shoushtari, A. N. (2022). Safety and efficacy of infrequent tebentafusp treatment omissions in patients with metastatic uveal melanoma. Ann. Oncol., 33 (7). S. S923 - 1. AMSTERDAM: ELSEVIER. ISSN 1569-8041
Schlaak, M., Schmidt, P., Bangard, C., Kurschat, P., Mauch, C. and Abken, H. (2012). Current Therapeutic approaches in the Treatment of metastatic malignant Melanoma. J. Dtsch. Dermatol. Ges., 10 (11). S. 858 - 860. HOBOKEN: WILEY-BLACKWELL. ISSN 1610-0379
Schran, S., Datta, R., Persa, O., Aguilar, C., Thelen, M., Lehmann, J., Garcia-Marquez, M., Wennhold, K., Quaas, A., Bruns, C., Mauch, C., Loeser, H., Stippel, D. and Schloesser, H. (2021). T- AND B-CELL ABUNDANCE ARE REMARKABLY REDUCED IN THE IMMUNE MICROENVIRONMENT OF POST-TRANSPLANT MALIGNANCIES. J. Immunother. Cancer, 9. S. A7 - 2. LONDON: BMJ PUBLISHING GROUP. ISSN 2051-1426
Striegel, A. K., Nazzal, R., Fabri, M., Rietschel, E., Doetsch, J., Mauch, C. and Tantcheva-Poor, I. (2014). Two Cases of Lupus vulgaris in Childhood and Review of the Clinical Challenges. Klinische Padiatr., 226 (1). S. 40 - 44. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-3824
Theurich, S., Rothschild, S. I., Hoffmann, M., Fabri, M., Sommer, A., Marquez, M. Garcia, Thelen, M., Schill, C., Merki, R., Schmid, T., Koeberle, D., Zippelius, A., Baues, C., Mauch, C., Tigges, C., Kreuter, A., von Bergwelt-Baildon, M. and Schlaak, M. (2016). Cytotoxic local tumor treatment in combination with xystemic Ipilimumab enhances the efficacy of this immunotherapy and prolongs overall survival in patients with advanced malignant melanoma. Oncol. Res. Treat., 39. S. 8 - 9. BASEL: KARGER. ISSN 2296-5262
Theurich, S., Rothschild, S., I, Hoffmann, M., Fabri, M., Sommer, A., Garcia-Marquez, M., Thelen, M., Schill, C., Merki, R., Schmid, T., Koeberle, D., Zippelius, A., Baues, C., Mauch, C., Tigges, C., Kreuter, A., Borggrefe, J., Schlaak, M. and von Bergwelt-Baildon, M. (2016). Local treatment of tumors or metastases in combination with systemic ipilimumab immunotherapy prolongs overall survival in patients with advanced malignant melanoma. Oncol. Res. Treat., 39. S. 103 - 105. BASEL: KARGER. ISSN 2296-5262
Weiss, J., Knuver, J., Schlaak, M., Kreuzer, K., Hallek, M. and Mauch, C. (2016). Minimal-invasive tumor monitoring of BRAF V600E positive tumors in cell-free plasma DNA. J. Dtsch. Dermatol. Ges., 14. S. 11 - 13. HOBOKEN: WILEY-BLACKWELL. ISSN 1610-0387
Wild, T., Altenburg, A., Karagiannidis, I., Mauch, C. and Zouboulis, C. C. (2016). Tumorogenesis and skin tumours in the elderly. Hautarzt, 67 (2). S. 132 - 140. NEW YORK: SPRINGER. ISSN 1432-1173
Zigrino, P., Brinckmann, J., Niehoff, A., Kadler, K. E. and Mauch, C. (2018). Fibroblast MMP-14 is necessary for skin homeostasis and contributes to delayed-type hypersensitivity in mice. Exp. Dermatol., 27 (3). S. E2 - 1. HOBOKEN: WILEY. ISSN 1600-0625
Zigrino, P., Brinckmann, J., Niehoff, A., Lu, Y., Giebeler, N., Eckes, B., Kadler, K. and Mauch, C. (2016). Fibroblast derived MMP-14 is the main collagenase for skin homeostasis. J. Invest. Dermatol., 136 (9). S. S258 - 1. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1523-1747